Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
about
Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patientsDose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinomaThe efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinomaA prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients.Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China.Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis.Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma.Validation of Delivery Consistency for Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy Plans.Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.
P2860
Q35683086-3BAA91D7-97A6-4C47-A5C7-A93186CB7D69Q36014280-6ADCE10E-96E9-4077-A879-86C2E1E95DDAQ36273672-9661F89B-5789-4566-8294-AD6E1B33E9D1Q36546073-E368FD2E-E08E-43EB-91EB-16717BB36125Q36905882-54242A79-75C7-4AF3-8C31-75DDEADA8BDBQ36925550-01ADB0DF-2FDC-4EEE-8984-0B0961BBB33AQ37190406-50C47CF4-BFF1-4F6D-A887-F0E3A849B872Q37225386-9971462D-0115-4680-9E9E-89408EF1DE62Q38336968-9872653C-3B4E-4E2E-9A89-846AE372AC49Q41349125-E0CDE00A-4CD9-4140-A529-207CB0D81B3EQ41451059-8C235421-9761-490F-9A05-F828A0E5DEF0Q47217686-C61C31F7-18CF-4EED-B2E3-964E37A32D27Q50352463-B9B7B2AA-D138-4269-BF65-0868315C319CQ52653712-DE2EB7E7-C0E2-45CE-BA37-CC969EDC76C5Q54253295-F13891D0-8AD1-4323-9167-BF0FEB890DB8Q55002736-FBFEB88E-6420-4485-A358-E633D11F3EA2Q55154377-DFBF4FBC-3670-46EB-A13A-5FFD6FEC75E1Q55379795-164D20C9-1705-4D8F-B8CC-32866D0D91EDQ55444686-040FD3E0-AF68-4A17-A67F-7DD3600C0985
P2860
Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Late toxicities after intensit ...... reatment-related risk factors.
@en
Late toxicities after intensit ...... reatment-related risk factors.
@nl
type
label
Late toxicities after intensit ...... reatment-related risk factors.
@en
Late toxicities after intensit ...... reatment-related risk factors.
@nl
prefLabel
Late toxicities after intensit ...... reatment-related risk factors.
@en
Late toxicities after intensit ...... reatment-related risk factors.
@nl
P2093
P2860
P356
P1476
Late toxicities after intensit ...... treatment-related risk factors
@en
P2093
P2860
P2888
P356
10.1038/BJC.2013.720
P407
P577
2013-11-19T00:00:00Z